Cibiltech
Paris
About Cibiltech
Cibiltech develops digital solutions for predictive medicine in renal transplantation. Cibiltech's algorithm helps nephrologists to better assess individual graft loss trajectory for each patient and to adjust treatment accordingly. This results in longer survival of the graft, an extended patient lifespan, and better clinical resources management.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $1.4M
- Last round: Grant (Mar 2023)
- Website: cibiltech.com
- Phone: +33 (0)975 381 261
Industries & Categories
Artificial Intelligence (AI), Electronic Health Record (EHR), Health Care, Information Technology, Medical
Social Profiles
Canonical: https://fsome.com/organization/cibiltech-66082 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.